“The best CDMO is the one you haven’t worked with.” says Audrey Greenberg.”That’s really unfortunate.. it’s not that hard to be a good service provider.” Audrey is the Founder of Centre for Breakthrough Medicines, the innovative, Pennsylvania-based Cell & Gene
SK bioscience has acquired a controlling stake in IDT Biologika, a German contract development and manufacturing organization (CDMO), for 339 billion won ($243.9 million). The deal, finalized through an agreement with the Klocke Group, gives SK bioscience 60% of IDT
SK Inc., the holding and investment company of South Korea’s SK Group, is in the final stages of negotiations to sell a major asset of its contract drug-making unit, SK Pharmteco Co., to Novo Nordisk A/S. The asset in question
SK pharmteco, a global contract development, manufacturing, and analytical testing organisation, has introduced Lentiviral Vector (LVV) Analytical Services. This suite of solutions is specifically designed for LVV and cell therapy programs. Coinciding with this launch, a new 20,000-square-foot CGMP testing
Ferring Pharmaceuticals has secured a long-term supplier for its bladder cancer gene therapy, Adstiladrin. The company has entered into an agreement with SK pharmteco, who will be responsible for the manufacture, testing, and release of the medicine. The partnership comes after
SK pharmteco Contract Manufacturing & Development (CDMO) Profile CDMO CDMO Services: Small Molecule; Cell & Gene Therapy Drug Substance Manufacturing (API); Analytical Development Solids Analytical Development; Cell Line Development; ICH Stability Testing; Process Development; Protein Synthesis Live Viral Vaccines; Viral
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
